Journal Article Ppublish 1 citation
PubMed: 42153390 DOI: 10.1093/jac/dkag157
Early bictegravir failure and emergence of R263K-mediated class-wide HIV integrase inhibitors resistance linked to over-the-counter supplement use.
J Antimicrob Chemother 81(6)
Authors: Elisa Minacori, Anaïs Lesourd, Camille Molkhou, Thomas Duflot, Jean-Jacques Parienti, Elodie Alessandri-Gradt
Affiliations
- Department of Virology, CHU Rouen Normandie, Rouen F-76000, France.
- Department of Infectious Disease, CHU Rouen Normandie, Rouen F-76000, France.
- Department of Pharmacology, Univ Rouen Normandie, INSERM U1096, CHU Rouen, Rouen F-76000, France.
- Department of Pharmacology, CIC-CRB 1404, Univ Rouen Normandie, INSERM U1096, CHU Rouen, Rouen F-76000, France.
- Department of Infectious Disease, Caen Normandie University, Univ Rouen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Caen, Caen F-14000, France.
- Department of Virology, Univ Rouen Normandie, Caen Normandie University, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Rouen F-76000, France.
MeSH
Hiv Integrase, Drug Therapy, Hiv, Hiv Integrase Inhibitors, Integrase Inhibitors, Integrases